Alkemata Morning Press Review — 7 September 2026
Cleaner-air policy meets climate-amplified smoke, Europe gains a commercial orbital launcher, a lithium mine faces a consultation ruling, and Alexander disease gets its first approved treatment.
Human-centred technology—from everyday life to deep engineering.
Daily concise press reviews on human-centred technology, science, public life and their practical consequences.
Cleaner-air policy meets climate-amplified smoke, Europe gains a commercial orbital launcher, a lithium mine faces a consultation ruling, and Alexander disease gets its first approved treatment.
Four consequential developments on voter-data limits, protection from AI-generated abuse, nuclear safety repairs and volcanic-ash disruption.
AI agents coordinating on a public wiki, Cuba’s infrastructure-linked health warning, attacks on medical aid in Ukraine, and Sydney’s extreme fire danger.
Four consequential updates on children’s online safety, AI in schools, EU browser regulation and the correction of an influential drought study.
Three evidence-led developments: rising newborn vitamin K non-receipt, a ruling preserving whistleblower fraud cases, and Texas testing speculative data-centre power demand.
Three consequential developments: Roman begins its journey, Iceland rejects reopening EU accession talks, and Nepal’s flood response shifts to hydropower-tunnel rescues.
Three developments about dependency and agency: Greenland’s contraception inquiry, Mounjaro’s cardiovascular indication, and Cursor’s planned loss of OpenAI models.
Five evidence-led developments on military AI limits, power-grid supply chains, updated COVID vaccines, a lettuce-linked outbreak and engineering after Nepal’s glacier collapse.
Four evidence-led developments: enforceable teen-platform limits, a medical-device cyber disruption, automated genetic-code prototyping and eruption warnings designed around real-world loss.
Five evidence-led developments: Brazil’s TikTok penalty, new Instagram trial evidence, Spain’s draft data-centre rules, antibody-image concerns and a detailed depression brain map.